{"id":"CHEMBL112797","canonicalSmiles":"CCCCP(=O)(O)CCCN","inchiKey":"ONNMDRQRSGKZCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SGS-742","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP-36742","LU-AE-58479","SGS742","Sgs 742","Sgs-742","Sgs742"],"crossReferences":{"drugbank":["DB05010"]},"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1161","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl","inchiKey":"WOFMFGQZHJDGCX-ZULDAHANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOMETASONE FUROATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asmanex","Asmanex hfa","Asmanex twisthaler","Elocon","Mometasone furoate","Nasonex","Sinuva"],"synonyms":["LAS-41002","LAS41002","LYR-210","LYR210","Lyr-210","Mometasone","Mometasone furoate","Mometasone furoate anhydrous","Mometasone furoate hydrate","Mometasone furoate monohydrate","Monovo","NSC-746171","NSC-760077","Nasonex","SCH 32088","SCH-32088"],"crossReferences":{"DailyMed":["mometasone%20furoate"],"PubChem":["144204256","170464666","56463118"],"Wikipedia":["Mometasone_furoate"],"drugbank":["DB14512"],"chEBI":["47564"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0007486","EFO_1001104","EFO_1001494","Orphanet_232","MONDO_0007254","MONDO_0005271","EFO_1001919","EFO_0000274","MONDO_0043771","HP_0100582","EFO_1002030","EFO_0000676","EFO_0002460","EFO_0004208","EFO_1001417","EFO_0005854","EFO_0008521","EFO_1000024","EFO_0000701","EFO_1002029","HP_0001742","EFO_0007187","EFO_0004232","HP_0006536","EFO_0004192","EFO_1000391","MONDO_0100096","MONDO_0004979","EFO_0000341","EFO_0003918","EFO_0003956","EFO_0007415"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 8 approved and 16 investigational indications."}
{"id":"CHEMBL1172928","canonicalSmiles":"C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1","inchiKey":"RCOBKSKAZMVBHT-TVQRCGJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADAFAXINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Radafaxine"],"crossReferences":{"Wikipedia":["Radafaxine"],"drugbank":["DB11790"]},"childChemblIds":["CHEMBL2107365"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1173462","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCCCCC(=O)O","inchiKey":"XEZVDURJDFGERA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICOSANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tricosanoic Acid"],"crossReferences":{"drugbank":["DB03500"],"chEBI":["42394"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200535","drugType":"Small molecule","blackBoxWarning":false,"name":"THALLOUS CHLORIDE TL 201","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4302512","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thallous chloride tl 201"],"synonyms":["201tl","Thallium (201 tl)","Thallium (201tl) chloride","Thallium chloride (201tl) injection","Thallium chloride tl-201","Thallium chloride, tl-201","Thallium tl-201","Thallium, isotope of mass 201","Thallium-201","Thallous chloride (201 tl)","Thallous chloride (201-tl)","Thallous chloride tl 201","Thallous chloride tl-201","Thallous chloride tl201","Thallous chloride, tl-201","Thallous chloride,tl-201","Tl 201","Tl201 element"],"crossReferences":{"DailyMed":["thallous%20chloride%20tl-201"],"chEBI":["32213"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for myocardial infarction and coronary artery disease."}
{"id":"CHEMBL1200690","canonicalSmiles":"NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"BJFIDCADFRDPIO-DZCXQCEKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LYPRESSIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diapid"],"synonyms":["8-l-lysinevasopressin","L-8","Lypressin","Lysine vasopressin","Vasopressin pig","Vasopressin, 8-l-lysine"],"crossReferences":{"PubChem":["144206455","144206977"],"drugbank":["DB14642"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200737","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@H](CO[P@](=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC","inchiKey":"KILNVBDSWZSGLL-KXQOOQHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLFOSCERIL PALMITATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["129-Y-83","129Y83","Colfosceril","Colfosceril palmitate","Dipalmitoyl glycerophosphocholine","Dipalmitoyl lecithin, l-","Dipalmitoylphosphatidylcholine","Dppc, l-","Dppc, r-"],"crossReferences":{"PubChem":["144206116","8139918"],"Wikipedia":["Colfosceril_palmitate"],"drugbank":["DB09114"],"chEBI":["72999"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for respiratory system disease and newborn respiratory distress syndrome."}
{"id":"CHEMBL1200778","canonicalSmiles":"C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1.Cl","inchiKey":"BIFMNMPSIYHKDN-FJXQXJEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXRAZOXANE HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1738","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexrazoxane hydrochloride","Totect","Zinecard"],"synonyms":["ADR-529 HYDROCHLORIDE","Cardioxan","Dexrazoxane hcl","Dexrazoxane hydrochloride","ICRF-187 HYDROCHLORIDE","Razoxane hydrochloride, (s)-","Savene"],"crossReferences":{"DailyMed":["dexrazoxane%20hydrochloride"],"chEBI":["50224"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for breast cancer and cardiomyopathy and has 9 investigational indications."}
{"id":"CHEMBL1200935","canonicalSmiles":"Br.NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1","inchiKey":"UQAVIASOPREUIT-VQIWEWKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARIFENACIN HYDROBROMIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1346","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Darifenacin hydrobromide","Emselex","Enablex"],"synonyms":["Darifenacin hbr","Darifenacin hydrobromide","UK-88525-04 (HYDROBROMIDE)","Uk-88525-04 (hbr)"],"crossReferences":{"DailyMed":["darifenacin%20hydrobromide"],"PubChem":["144206189","170465079"],"chEBI":["31455"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0006865","EFO_1000781"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for overactive bladder and urgency urinary incontinence."}
{"id":"CHEMBL1201016","canonicalSmiles":"COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)[C@@H](NC(=O)/C(=N\\OC)c3csc(N)n3)[C@H]2SC1","inchiKey":"LTINZAODLRIQIX-FBXRGJNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPODOXIME PROXETIL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banan","Cefpodoxime proxetil","Vantin"],"synonyms":["CS-807","Cefpodoxime proxetil","NSC-759161","U-76252"],"crossReferences":{"DailyMed":["cefpodoxime%20proxetil"],"PubChem":["144206928","144206978"],"chEBI":["3505"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for otitis media and has 1 investigational indication."}
{"id":"CHEMBL1201229","canonicalSmiles":"CN(CCCCCCCCCCN(C)C(=O)Oc1cccc([N+](C)(C)C)c1)C(=O)Oc1cccc([N+](C)(C)C)c1","inchiKey":"RWZVPVOZTJJMNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECARIUM","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Demecarium","Demecarium cation","Demecarium ion"],"crossReferences":{"drugbank":["DB00944"],"chEBI":["59719"]},"childChemblIds":["CHEMBL1200514"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for glaucoma."}
{"id":"CHEMBL1201470","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCODONE POLISTIREX","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1457","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocodone polistirex"],"crossReferences":{"DailyMed":["hydrocodone%20polistirex"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1201483","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE POLISTIREX","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pseudo-12"],"synonyms":["Pseudoephedrine polistirex"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1207366","canonicalSmiles":"O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1","inchiKey":"XDKRVNKVAKCFGW-FOCLMDBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW468816","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW468816","Gw-468816","Gw468816"],"childChemblIds":["CHEMBL400007"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000161509","ENSG00000116032","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0003768"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1210221","canonicalSmiles":"CCCCC/C=C/C=C1\\C(=O)C=C[C@@H]1C/C=C/CCCC(=O)O","inchiKey":"VHRUMKCAEVRUBK-XOVNXQNQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1210221","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08435"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222151","canonicalSmiles":"CCCCCCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"HEGSGKPQLMEBJL-MBJXGIAVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Octyl Beta-D-Galactoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octyl Beta-D-Galactoside"],"crossReferences":{"drugbank":["DB07924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1224","canonicalSmiles":"Cc1ccc(/C(=C\\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1","inchiKey":"PWACSDKDOHSSQD-IUTFFREVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACRIVASTINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benadryl allgy relief plus decongest","Semprex"],"synonyms":["Acrivastine","BW 825C","BW-825C"],"crossReferences":{"PubChem":["144206566"],"Wikipedia":["Acrivastine"],"drugbank":["DB09488"],"chEBI":["83168"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994 and is indicated for allergic disease."}
{"id":"CHEMBL1230134","canonicalSmiles":"COc1ccc(-n2cnc3ccc(-c4n[nH]c(=S)o4)cc32)cc1","inchiKey":"QBVJMUOTMRYUKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230134","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07058"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231469","canonicalSmiles":"O=C1Nc2ccc(Br)cc2/C1=C1/Nc2ccccc2C1=O","inchiKey":"IEQQJQHHJMQETK-YPKPFQOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231469","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["534343"],"drugbank":["DB07493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234886","canonicalSmiles":"O=O","inchiKey":"MYMOFIZGZYHOMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYGEN","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dioxygen","E-948","E948","INS NO.948","INS-948","Molecular oxygen","Oxygen","Oxygen 93 percent","Oxygen molecule","Oxygenium","RNS-60 COMPONENT OXYGEN","RNS60 COMPONENT OXYGEN"],"crossReferences":{"drugbank":["DB09140"],"chEBI":["15379"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 73 investigational indications."}
{"id":"CHEMBL1235421","canonicalSmiles":"O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2","inchiKey":"MMXZSJMASHPLLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRROLOQUINOLINE QUINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03205"],"chEBI":["18315"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236003","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)CP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"KJNLSEOJEFDELT-JJNLEZRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADENOSINE PHOSPHONOACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5'-O-Phosphonylacetyladenosine"],"crossReferences":{"drugbank":["DB02607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236183","canonicalSmiles":"O=C(CO)[C@@H](O)[C@@H](O)[C@H](O)CO","inchiKey":"BJHIKXHVCXFQLS-PQLUHFTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAGATOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-tagatose","Tagatose"],"crossReferences":{"drugbank":["DB04936"],"chEBI":["47693"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL124493","canonicalSmiles":"C[C@](O)(COc1c(F)c(F)c(F)c(F)c1F)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"MMNRWNREMUMYQG-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL124493","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1254709","canonicalSmiles":"Clc1ccc2c(NCCCN3CCC(NC(c4ccccn4)c4ccccn4)CC3)ccnc2c1","inchiKey":"QRCZXFIANKOFOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DM-1157","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DM1157","Dm-1157","Dm1157","PL-69","PL69"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1254990","canonicalSmiles":"C[C@H](CC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"QYYDXDSPYPOWRO-JHMCBHKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORUCHOLIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["24-norursodeoxycholic acid","Nor-ursodeoxycholic acid","Norucholic acid","Norursodeoxycholic acid"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1272","canonicalSmiles":"CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O","inchiKey":"FAEKWTJYAYMJKF-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPAGLINIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enyglid","Novonorm","Prandin","Repaglinide"],"synonyms":["A10BX02","AG-EE 623 ZW","AG-EE-623-ZW","AG-EE-623ZW","AGEE-623ZW","NSC-759893","Prandin","Repaglinide"],"crossReferences":{"DailyMed":["repaglinide"],"PubChem":["11112894","144204272","26719812","49648522"],"Wikipedia":["Repaglinide"],"drugbank":["DB00912"],"chEBI":["8805"]},"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0003914","Orphanet_68380","HP_0003124","EFO_0001068","MONDO_0005180","EFO_0001645","Orphanet_44890","Orphanet_586","MONDO_0005148","EFO_0000400","MONDO_0008315","EFO_0000537"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 9 investigational indications."}
{"id":"CHEMBL129788","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1OCCCOc1cc(Cl)c(Cl)cc1Cl","inchiKey":"MJZJYWCQPMNPRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WR-99210","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WR-99210"],"crossReferences":{"drugbank":["DB08734"]},"childChemblIds":["CHEMBL545921"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL130880","canonicalSmiles":"Nc1c2c(nc3c1CCC3)CCCC2","inchiKey":"YLUSMKAJIQOXPV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPIDACRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipidacrine"],"crossReferences":{"PubChem":["26719760"],"drugbank":["DB13668"]},"childChemblIds":["CHEMBL1898637"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1377575","canonicalSmiles":"CC1CC(OC(=O)c2ccccc2O)CC(C)(C)C1","inchiKey":"WSSJONWNBBTCMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMOSALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Heliophan"],"synonyms":["Eusolex","Homomenthyl salicylate","Homosalate","NSC-164918"],"crossReferences":{"PubChem":["144204725","144209307","144213399","170465478","17389300","26747404"],"drugbank":["DB11064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL145347","canonicalSmiles":"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)[C@H]1O[C@](CC)([C@H]2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C","inchiKey":"BBMULGJBVDDDNI-OWKLGTHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LASALOCID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lasalocid","Lasalocid a","NSC-243048","RO 2-2985","RO-2-2985","RO-22985"],"crossReferences":{"Wikipedia":["Lasalocid"],"drugbank":["DB11423"]},"childChemblIds":["CHEMBL1489769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628234","canonicalSmiles":"CN(C)CCC=C1c2ccccc2COc2ccccc21.Cl","inchiKey":"MHNSPTUQQIYJOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXEPIN HYDROCHLORIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1628227","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adapin","Doxepin hydrochloride","Quitaxon","Silenor","Sinequan","Xepin","Zonalon"],"synonyms":["Doxepin hcl","Doxepin hydrochloride","NSC-108160","P-3693A"],"crossReferences":{"DailyMed":["doxepin%20hydrochloride"],"PubChem":["26719773","26748009"]},"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","EFO_0003761","EFO_0000274","MONDO_0007079","EFO_0003843","EFO_0004698","EFO_1001904"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and has 5 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL168815","canonicalSmiles":"CC1OC2(CS1)CN1CCC2CC1","inchiKey":"WUTYZMFRCNBCHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEVIMELINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cevimeline"],"crossReferences":{"DailyMed":["cevimeline%20hydrochloride"]},"childChemblIds":["CHEMBL2218917"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0009869"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for xerostomia and has 1 investigational indication."}
{"id":"CHEMBL1743047","drugType":"Antibody","blackBoxWarning":true,"name":"NECITUMUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["11F8","IMC-11F8","Necitumumab","Portrazza"],"crossReferences":{"DailyMed":["necitumumab"],"DrugCentral":["5071"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000708","EFO_0000707","EFO_0003060","EFO_0009708"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for neoplasm and non-small cell lung carcinoma and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1751","canonicalSmiles":"C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O","inchiKey":"LTMHDMANZUZIPE-PUGKRICDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGOXIN","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Digamex","Digoxin","Digoxin pediatric","Lanoxicaps","Lanoxin","Lanoxin pediatric","Lanoxin-125","Lanoxin-pg","Vanoxin"],"synonyms":["Digoxin","Digoxinum","Dynamos","Fargoxin","Lanocardin","Mapluxin","NSC-95100","Natigoxin","Rougoxin","Stillacor-","Toloxin","Vanoxin"],"crossReferences":{"DailyMed":["digoxin"],"PubChem":["11533002","144204576","144208876","144213367","17389540","26752810","49718191","50105460","56422204"],"Wikipedia":["Digoxin"],"drugbank":["DB00390"],"chEBI":["4551"]},"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000105409","ENSG00000132681"],"count":4},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000558","EFO_0000275","MONDO_0002009","EFO_0000756","EFO_1001249","MONDO_0007254","EFO_0000373","Orphanet_91378","Orphanet_892","EFO_1000044","EFO_0000474","MONDO_0002050","EFO_0000544","HP_0004755","EFO_0003144","EFO_0003047","EFO_0000400","EFO_0000198","EFO_0000616","EFO_0002618","EFO_0000685","EFO_0006859","EFO_0006911","Orphanet_238557","EFO_0000222","EFO_0000319","EFO_0003060","MONDO_0008315","EFO_0002496","EFO_0004239","MP_0001845","EFO_0003890","MONDO_0001134","EFO_0000764","EFO_0007328","MONDO_0005148","EFO_0001062"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 4 approved and 30 investigational indications."}
{"id":"CHEMBL181936","canonicalSmiles":"C[C@@H]1c2cc(O)ccc2O[C@@H](c2ccc(OCCN3CCCC3)cc2)[C@H]1c1ccc(O)cc1","inchiKey":"XPVKGTWRXBSJKO-LHXLBICKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL181936","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07567"],"chEBI":["41593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1980391","canonicalSmiles":"COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2","inchiKey":"UOVCGJXDGOGOCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-1530","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-1530","RG-1530","Rg-1530"],"crossReferences":{"PubChem":["103905607"]},"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000066468","ENSG00000102755","ENSG00000037280","ENSG00000077782","ENSG00000113721","ENSG00000122025","ENSG00000142731"],"count":9},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL203321","canonicalSmiles":"CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O","inchiKey":"WXJFKKQWPMNTIM-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BRINCIDOFOVIR","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tembexa"],"synonyms":["Brincidofovir","CMX 001","CMX-001","CMX001","Hdp-cidofovir","Hexadecyloxypropyl cidofovir","Hexadecyloxypropyl-cidofovir"],"crossReferences":{"drugbank":["DB12151"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for smallpox and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104386","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O","inchiKey":"NSQLIUXCMFBZME-MPVJKSABSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CARPERITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atrial natriuretic peptide","Atrial natriuretic peptide carperitide","Carperitide","SUN 4936","SUN-4936"],"description":"Protein drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2104398","canonicalSmiles":"OCC(O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"SERLAGPUMNYUCK-BLEZHGCXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOMALT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY I 3930","BAY-I-3930","C-isomaltidex","E-953","Hydrogenated isomaltulose","INS NO.953","INS-953","Isomalt","Isomaltitol","Palatinit"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105845","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CCOC(=O)[C@@H](N)C(C)C)Cn1cnc2c(=O)[nH]c(N)nc21","inchiKey":"ACBSZTQIFTYFGH-IAPPQJPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOMACICLOVIR STEARATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-174606.0","ABT-606","MIV 606","MIV-606","Valomaciclovir stearate"],"crossReferences":{"drugbank":["DB15651"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105941","canonicalSmiles":"CCC1(CCC(C)C)C(=O)N=C([O-])NC1=O.[Na+]","inchiKey":"BNHGKKNINBGEQL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOBARBITAL SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL267894","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Amytal sodium","Sod amytal","Talamo"],"synonyms":["Amobarbital sodium","Amobarbital sodium for injection","Amobarbital sodium salt"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL2106841","canonicalSmiles":"CCCCCC(C)C(C)c1cc(O)c2c(c1)OC(C)(C)C=C2c1ccncc1","inchiKey":"YHUDSHIRWOVVCV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NONABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRL 4664","Brl-4664","Nonabine"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107456","canonicalSmiles":"CCCC[C@H](C)C[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC/C=C/C(=O)O","inchiKey":"OJZYRQPMEIEQFC-UAWLTFRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIMAPROST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Limaprost","Limaprost alfadex","Limaprost alpha-cyclodextrin clathrate"],"crossReferences":{"drugbank":["DB09211"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107820","canonicalSmiles":"COc1ccc(NC(=O)[C@H](CCCCN)NC(=O)c2cc(NC(=O)[C@H](CCCCN)NC(=O)c3cc(NC(=O)[C@H](CCCCN)NC(=O)c4cc(NC(=O)[C@@H](N)CCCCN)ccc4OC)ccc3OC)ccc2OC)cc1C(N)=O","inchiKey":"PWFIFNGOPQUNIT-ITMZJIMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELPARANTAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pmx 60056"],"synonyms":["Delparantag","PMX 60056","PMX-60056","Pmx-60056"],"crossReferences":{"drugbank":["DB12955"]},"childChemblIds":["CHEMBL2107828"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108054","drugType":"Protein","blackBoxWarning":false,"name":"TADEKINIG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tadekinig alfa"],"linkedTargets":{"rows":["ENSG00000150782"],"count":1},"linkedDiseases":{"rows":["EFO_0007135"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108080","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"PARNAPARIN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluxum","Lowepa","Minidalton","OP 21-23","OP-21-23","OP-2123","Parnaparin sodium","Tromboparin"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108266","drugType":"Antibody","blackBoxWarning":false,"name":"CEDELIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cedelizumab","ORTHOCLONE OKT4 A","RWJ 49004","RWJ-49004"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108489","drugType":"Antibody","blackBoxWarning":false,"name":"KELIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-CE9.1","Keliximab","SB-210396"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108581","drugType":"Antibody","blackBoxWarning":false,"name":"CATUMAXOMAB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Removab"],"synonyms":["Catumaxomab"],"linkedTargets":{"rows":["ENSG00000119888","ENSG00000167286","ENSG00000198851","ENSG00000160654"],"count":4},"linkedDiseases":{"rows":["HP_0001541","EFO_0000616","EFO_0003897","EFO_0000294","EFO_1001100","EFO_0000503","MONDO_0008170","EFO_1000251","EFO_0000313","MONDO_0001187","EFO_0000311"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cancer and neoplasm and has 8 investigational indications."}
{"id":"CHEMBL2108888","drugType":"Enzyme","blackBoxWarning":false,"name":"AGALSIDASE BETA","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fabrazyme"],"synonyms":[".alpha.--galactosidase","Agalsidase beta","Agalsidase beta (genetical recombination)"],"crossReferences":{"DailyMed":["agalsidase%20beta"],"DrugCentral":["5018"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for fabry disease."}
{"id":"CHEMBL2109065","drugType":"Unknown","blackBoxWarning":false,"name":"DROTRECOGIN ALFA (ACTIVATED)","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"year":2011},"tradeNames":["Xigris"],"synonyms":["Activated protein c","Drotrecogin alfa","Drotrecogin alfa (activated)","Drotrecogin alfa activated","Drotrecogin alfa, activated","Drotrecogin-alfa","LY-203638","LY203638"],"linkedTargets":{"rows":["ENSG00000198734","ENSG00000185010"],"count":2},"linkedDiseases":{"rows":["HP_0100806","EFO_0006834","MONDO_0100130","EFO_0003827","EFO_0000712","EFO_0003884","EFO_1000652","HP_0004419","EFO_0005251"],"count":9},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for recurrent thrombophlebitis and has 7 investigational indications. It was withdrawn in European Union  in 2011."}
{"id":"CHEMBL2109402","drugType":"Antibody","blackBoxWarning":false,"name":"MM-121","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MM-121","SAR-256212"],"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002158","MONDO_0008170","MONDO_0007254","MONDO_0002087","EFO_0003060","EFO_0000311"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109567","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-564","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-564"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109630","drugType":"Antibody","blackBoxWarning":false,"name":"BC8 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BC8","Bc8 131i"],"linkedTargets":{"rows":["ENSG00000081237"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000222","EFO_0001378"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110568","drugType":"Small molecule","blackBoxWarning":false,"name":"CHROMIC PHOSPHATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1200676"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL2110912","canonicalSmiles":"O=C(OCCN1CCCCC1)C1(C2CCCCC2)CCCCC1","inchiKey":"MNSQDVCVWNXBFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHEXYVERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihexyverine"],"crossReferences":{"drugbank":["DB13678"]},"childChemblIds":["CHEMBL2106632"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2146095","canonicalSmiles":"O=C1O[C@H]([C@@H](O)CO)C([O-])=C1O.O=C1O[C@H]([C@@H](O)CO)C([O-])=C1O.[Ca+2]","inchiKey":"BLORRZQTHNGFTI-ZZMNMWMASA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM ASCORBATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ascorbic acid calcium salt","Calcium ascorbate","Calcium ascorbate (e 302)","Calcium ascorbate anhydrous","Calcium ascorbate dihydrate","Calcium diascorbate","Calcium l-ascorbate dihydrate","E 302","E-302","Ester-c","INS NO.302","INS-302","Vitamin c (as calcium ascorbate)"],"crossReferences":{"drugbank":["DB14483"]},"childChemblIds":["CHEMBL3184533"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2205807","canonicalSmiles":"Cc1ccc(-c2ccc(C)cn2)nc1","inchiKey":"PTRATZCAGVBFIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABAMETAPIR","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xeglyze"],"synonyms":["5,5'-dimethyl-2,2'-dipyridyl","6,6'-bi-3-picoline","Abametapir","HA-44","Ha44"],"crossReferences":{"drugbank":["DB11932"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for lice infestation."}
{"id":"CHEMBL222813","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](NC(=N)N)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"ARAIBEBZBOPLMB-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZANAMIVIR","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relenza"],"synonyms":["GG-167","GG167","GR 121167X","GR-121167","GR-121167X","Relenza","Zanamivir"],"crossReferences":{"DailyMed":["zanamivir"],"PubChem":["144205743","170464662"],"Wikipedia":["Zanamivir"],"drugbank":["DB00558"],"chEBI":["50663"]},"childChemblIds":["CHEMBL3330707","CHEMBL57705","CHEMBL1673195"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for viral disease and influenza and has 3 investigational indications."}
{"id":"CHEMBL227552","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H]1O","inchiKey":"WFPZSXYXPSUOPY-ROYWQJLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227552","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01774"],"chEBI":["15751"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267447","canonicalSmiles":"CCCc1cc(=O)oc2c3c(c4c(c12)OC(C)(C)C=C4)O[C@H](C)[C@@H](C)[C@@H]3O","inchiKey":"NIDRYBLTWYFCFV-FMTVUPSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-CALANOLIDE A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Calanolide_A"],"drugbank":["DB04886"],"chEBI":["65552"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273386","canonicalSmiles":"O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1","inchiKey":"UFBJCMHMOXMLKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,4-DINITROPHENOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-dinitrophenol","2,4-dinitrophenol","Aldifen","Chemox","Dinitrophenol","Dinofan","Fenoxyl carbon n","MP-101","Mitcal","Mp-101","NSC-1532","Nitrophen","Nitrophene","SR-1C5"],"crossReferences":{"PubChem":["144208660","144210350","17389906","26747391","47193722"],"Wikipedia":["2,4-Dinitrophenol"],"drugbank":["DB04528"],"chEBI":["42017"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL292687","canonicalSmiles":"O=[N+]([O-])c1ccc(Cl)c([N+](=O)[O-])c1","inchiKey":"VYZAHLCBVHPDDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINITROCHLOROBENZENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-chloro-2,4-dinitrobenzene","Dinitrochlorobenzene","NSC-6292"],"crossReferences":{"PubChem":["124892793","144209154","144213119","26757478","57260144","57264331"],"drugbank":["DB11831"],"chEBI":["34718"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3039596","canonicalSmiles":"CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)[O-])C(C)C.[Na+]","inchiKey":"TVTJZMHAIQQZTL-WATAJHSMSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSINOPRIL SODIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039598","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosinopril sodium","Fositens","Fozitec","Monopril","Staril"],"synonyms":["Fosenopril sodium","Fosinopril sodium","Fosinopril sodium salt","SQ 28555","SQ-28555"],"crossReferences":{"DailyMed":["fosinopril%20sodium"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for heart failure and hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3137316","canonicalSmiles":"Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](OP(=O)(O)O)(C(F)(F)F)CC[C@@]21Cc1ccccc1","inchiKey":"BVXLAHSJXXSWFF-KEKPKEOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSDAGROCORAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosdagrocorat","PF-04171327"],"crossReferences":{"drugbank":["DB12198"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3137347","drugType":"Antibody","blackBoxWarning":false,"name":"VARLILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-1127","Varlilumab"],"linkedTargets":{"rows":["ENSG00000139193"],"count":1},"linkedDiseases":{"rows":["EFO_0000630","EFO_0003863","EFO_1001956","EFO_0000756","EFO_0000681","EFO_0000574","EFO_0000272","EFO_0000519","EFO_0003060","EFO_0000632","EFO_1001961"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL32010","canonicalSmiles":"OC1CCCCC1","inchiKey":"HPXRVTGHNJAIIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOHEXANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclohexanol"],"crossReferences":{"PubChem":["144208679","144213120","49816808"],"Wikipedia":["Cyclohexanol"],"drugbank":["DB03703"],"chEBI":["18099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3234035","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c([C@H]2CC(=O)[C@H]3C[C@@H]2C3(C)C)c(OC(=O)/C=C/C(=O)O)c1","inchiKey":"GSTZHANFXAKPSE-MXTREEOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3234035","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05048"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326294","canonicalSmiles":"O=C1Nc2ccccc2C1=O","inchiKey":"JXDYKVIHCLTXOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isatin"],"crossReferences":{"PubChem":["144210074","47193744"],"Wikipedia":["Isatin"],"drugbank":["DB02095"],"chEBI":["27539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3348846","canonicalSmiles":"COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1","inchiKey":"VRQMAABPASPXMW-HDICACEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3348846","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12247"],"chEBI":["63453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL33864","canonicalSmiles":"O=C(O)CCCCC1CCSS1","inchiKey":"AGBQKNBQESQNJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIPOIC ACID, ALPHA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thioctacid"],"synonyms":[".alpha.-lipoic acid","6,8-thioctic acid","A-lipoicum acidum","Acidum thiocticum","Alpha lipoic acid","Alpha-lipoic acid","Biletan","Dl-6,8-thioctic acid","Lipoic acid, alpha","Lipoic acid, dl-","NSC-628502","NSC-90788","Thiocacid","Thioctan","Thioctate","Thioctic acid","Thioctic acid dl-form","Tioctic acid"],"crossReferences":{"PubChem":["104171254","11532893","124881686","144203836","144209006","144213409","170465713","17388693","26747265","26752825","397475","50105475","57260117"],"chEBI":["16494"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL3545239","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05019702","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRA-027","Pf-05019702","WAY-257027"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000731"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL363387","canonicalSmiles":"O=C(O)Cn1cc(Cc2nc3c(F)c(F)cc(F)c3s2)c2ccccc21","inchiKey":"KYHVTMFADJNSGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIDORESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EML 676","EML-676","IDD 676","IDD-000676","IDD-000676-01","IDD-676","Lidorestat","Lidorestat anhydrous","Lindolrestat","Lindorestat"],"crossReferences":{"drugbank":["DB07063"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707285","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC HYDROXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferric hydroxide"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707350","canonicalSmiles":"C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1.CS(=O)(=O)O","inchiKey":"ALDUQYYVQWGTMR-GJFSDDNBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAQUOTINIB MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3663929","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-8273 MESILATE","ASP-8273 MESYLATE","ASP8273 mesilate","Naquotinib mesilate","Naquotinib mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3806158","canonicalSmiles":"CCCCCC[C@@H]1CCc2cc([C@H]3CC[C@](N)(CO)C3)ccc2C1","inchiKey":"BPMMYKAHRIEVDH-VOQZNFBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986104","Bms-986104"],"crossReferences":{"drugbank":["DB15214"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3809901","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)C(C)C","inchiKey":"NXUWTKIOMJSLSV-DEEZXRHXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"MMI-0100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MMI 0100","Mmi-0100"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL396416","canonicalSmiles":"N[C@@H](CSCC(=O)O)C(=O)O","inchiKey":"GBFLZEXEOZUWRN-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOCYSTEINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loviscol","Mucodyne","Mucodyne fte","Mucofan","Mucolex","Pulmoclase"],"synonyms":["AHR-3053","Carbocistein","Carbocisteine","Carbocit","Carbocysteine","Carbocysteine dl-form","Carbocysteine, dl-","Dl-3-(carboxymethylthio)alanine","L-carbocisteine","L-carbocysteine","LJ 206","LJ-206","Lisomucil","Methista","Muciclar","Mucocis","Mucolase","Mucopront","NSC-14156","NSC-68427","Pectox","R05CB03","Reomucil","Rhinathiol","Siroxyl","Transbronchin"],"crossReferences":{"Wikipedia":["Carbocisteine"],"drugbank":["DB04339"],"chEBI":["16163"]},"childChemblIds":["CHEMBL4303635"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3989949","canonicalSmiles":"NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl","inchiKey":"GFHAXPJGXSQLPT-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENOBAMATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xcopri"],"synonyms":["Cenobamate","YKP-3089","YKP3089"],"crossReferences":{"DailyMed":["cenobamate"],"drugbank":["DB06119"]},"linkedTargets":{"rows":["ENSG00000163288","ENSG00000136546","ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000168356","ENSG00000166206","ENSG00000007314","ENSG00000196876","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000185313","ENSG00000183873","ENSG00000144285","ENSG00000094755","ENSG00000169432","ENSG00000113327","ENSG00000163285","ENSG00000268089","ENSG00000136531","ENSG00000186297","ENSG00000153253"],"count":26},"linkedDiseases":{"rows":["EFO_0000474","EFO_0004263","EFO_0001421","HP_0001250"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for epilepsy and seizure and has 2 investigational indications."}
{"id":"CHEMBL3989976","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGVORHYALURONIDASE ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PEGPH-20","PEGPH20","Pegvorhyaluronidase alfa"],"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL413","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"QFJCIRLUMZQUOT-HPLJOQBZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SIROLIMUS","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapamune","Sirolimus"],"synonyms":["AY-22989","L04AA10","NSC-226080","Npc-12g","Rapalimus","Rapamycin","SM-88 COMPONENT SIROLIMUS","Sirolimus","WY-090217"],"crossReferences":{"DailyMed":["sirolimus"],"PubChem":["124886754","144204421","144206303","50103901"],"Wikipedia":["Sirolimus"],"drugbank":["DB00877"],"chEBI":["9168"]},"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["Orphanet_122","EFO_0000637","EFO_0007323","EFO_0000681","EFO_0000401","Orphanet_1059","EFO_0005952","EFO_1000653","EFO_0000339","EFO_0002690","MONDO_0008903","EFO_0003884","EFO_1000251","EFO_0000514","EFO_1000882","MONDO_0004976","EFO_0008517","EFO_0000760","Orphanet_379","EFO_0000198","MONDO_0013730","EFO_0002618","MONDO_0005149","EFO_1000811","Orphanet_2309","Orphanet_46724","EFO_1000906","EFO_0000180","Orphanet_636","EFO_0002424","EFO_1001946","EFO_1001968","MONDO_0004986","EFO_1001496","EFO_0000384","MONDO_0008315","MONDO_0002691","GO_0007568","HP_0002721","MONDO_0009453","EFO_0009259","Orphanet_2869","EFO_0000574","Orphanet_101997","EFO_0001378","MONDO_0015564","EFO_0001062","EFO_0004610","EFO_0003086","Orphanet_84","EFO_0001365","EFO_0002913","EFO_1001465","MONDO_0007254","MONDO_0016236","EFO_1000637","EFO_0003966","EFO_0006888","MONDO_0002050","Orphanet_77260","MONDO_0002898","MONDO_0005180","EFO_0000196","Orphanet_805","EFO_0000183","Orphanet_447","EFO_0000616","MONDO_0019457","EFO_0001645","EFO_0000403","EFO_0009661","Orphanet_1063","EFO_0000222","EFO_0003929","EFO_0004198","EFO_0004599","EFO_0000537","Orphanet_624","MONDO_0002603","EFO_0000764","EFO_0006927","EFO_0000702","EFO_1001947","MONDO_0024880","EFO_1001927","EFO_0000519","EFO_0004265","MONDO_0000873","EFO_0004683","EFO_0001075","Orphanet_183660","EFO_0000571","EFO_1000657","Orphanet_848","MONDO_0002177","EFO_0000540","EFO_0003913","EFO_0000565","Orphanet_365","MONDO_0002280","HP_0001871","EFO_0003870","EFO_0000544","Orphanet_733","EFO_0000182","MONDO_0018531","MONDO_0019063","EFO_1000749","EFO_0005761","EFO_0008620","HP_0003124","EFO_0000220","MONDO_0002108","EFO_0004224","EFO_1001466","EFO_0009907","MONDO_0018848","EFO_0004236","EFO_0004194","MONDO_0044881","EFO_1001119","EFO_0009708","EFO_1001050","MP_0001845","EFO_1000986","MONDO_0100096","EFO_0000731","MONDO_0037255","Orphanet_282","Orphanet_232","MONDO_0015686","EFO_1000475","EFO_0000708","Orphanet_538","HP_0001915","EFO_1001469","EFO_1002048","MONDO_0001187","MONDO_0001718","EFO_1001480","EFO_1000044","EFO_0003144","Orphanet_309144","Orphanet_93460","EFO_0003047","MONDO_0007079","EFO_0009321","EFO_0000717","EFO_1000158","EFO_0003770","EFO_0003060","EFO_0000621","Orphanet_3205","EFO_0000311","MONDO_0001705","HP_0001626","EFO_0000095","EFO_0006475","MONDO_0005147","EFO_0001421","EFO_0008583","EFO_0000691","MONDO_0021637"],"count":163},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for eye disease and immune system disease and has 120 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4209111","canonicalSmiles":"NC(=O)Cc1ccc(Nc2cc(C(F)(F)F)nc(-c3cccc(Cl)c3)n2)cc1","inchiKey":"KRRGWHSEDYQKDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4209111","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL427216","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1","inchiKey":"BOVGTQGAOIONJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLICLAZIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bilxona","Dacadis mr","Diaglyk","Diamicron","Diamicron mr","Edicil","Glimil","Nazdol mr","Vamju","Vitile xl","Ziclaseg","Zicron","Zicron pr"],"synonyms":["Gliclazide","Glimicron","J3.151H","NSC-758673","S-1702","S-852","SE 1702","SE-1702"],"crossReferences":{"PubChem":["144204141","170465698","26748918","26748919","26748920","49646130"],"Wikipedia":["Gliclazide"],"drugbank":["DB01120"],"chEBI":["31654"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL429317","canonicalSmiles":"Cc1cc(/C(=C/Nc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)on1","inchiKey":"VMAKIACTLSBBIY-BOPFTXTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVL-3288","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anvylic-3288","Avl-3288","CCMI","UCI-4083","XY-4083"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005411"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297229","drugType":"Unknown","blackBoxWarning":true,"name":"PRABOTULINUMTOXIN A","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jeuveau"],"synonyms":["ABP 450","ABP-450","Botulinum toxin type a complex","DWP-450","DWP450","Prabotulinumtoxin a","Prabotulinumtoxina-xvfs"],"linkedTargets":{"rows":["ENSG00000132639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277","HP_0000473","EFO_0005422"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for skin aging and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297536","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PATISIRAN SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Onpattro"],"synonyms":["Patisiran sodium"],"crossReferences":{"DailyMed":["patisiran%20sodium"]},"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_0009562","EFO_1001875","Orphanet_85447"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved indications."}
{"id":"CHEMBL4298108","drugType":"Enzyme","blackBoxWarning":false,"name":"BIFUNCTIONAL EPOXIDE HYDROLASE 2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bifunctional epoxide hydrolase 2","Cytosolic epoxide hydrolase 2","Ephx2","Soluble epoxide hydrolase"],"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4301787","canonicalSmiles":"CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(=S)S","inchiKey":"IBVJFULICYLKCE-BDVNFPICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOX-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297472"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4521078","canonicalSmiles":"Cc1noc(C)c1-c1cnc2c(-c3ccc(C(=O)O)cc3)cn([C@@H](C)c3ccccn3)c2c1","inchiKey":"AMSUHYUVOVCWTP-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-51107","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brd4 inhibitor plx51107","PLX-51107","Plx 51107","Plx-51107"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4583691","canonicalSmiles":"Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(N2CCOCC2)c1","inchiKey":"UEPXBTCUIIGYCY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LXH254","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LXH-254","LXH254","Lxh 254","Lxh254","Naporafenib","PAN-RAF INHIBITOR LXH254"],"linkedTargets":{"rows":["ENSG00000157764","ENSG00000132155"],"count":2},"linkedDiseases":{"rows":["EFO_0000756","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594214","canonicalSmiles":"CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC3=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O","inchiKey":"BPKIMPVREBSLAJ-QTBYCLKRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ZICONOTIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prialt"],"synonyms":[".omega.-conotoxin m viia","SNX-111","Ziconotide"],"linkedTargets":{"rows":["ENSG00000148408"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003100","HP_0001945","EFO_0003843"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for pain and fever."}
{"id":"CHEMBL4594355","drugType":"Unknown","blackBoxWarning":false,"name":"APL-501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APL-501","Apl-501","CBT-501","GB-226","GB226","Gb226","Genolimzumab","Geptanolimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000211","EFO_1001480","EFO_0000096","MONDO_0002974","EFO_0003060","EFO_0000311","EFO_0007143"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4594495","drugType":"Unknown","blackBoxWarning":false,"name":"SC-006","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antibody-drug conjugate sc-006","SC-006","SC006","Sc-006"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594520","drugType":"Unknown","blackBoxWarning":false,"name":"AMG-224","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 224","AMG-224","Amg 224","Amg-224","Anti-bcma-mcc-dm1"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650362","canonicalSmiles":"Cc1cc(N2CCN(c3ccc(C(=O)Nc4ccc(F)cc4)cc3)CC2)ccc1OC[C@@H]1CO[C@@](Cn2cncn2)(c2ccc(F)cc2F)C1","inchiKey":"OSAMZQJKSCAOHA-CWRQMEKBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OPELCONAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Opelconazole","Opelconazole(inn)","PC-945","PC945","Pc945"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802221","drugType":"Antibody","blackBoxWarning":false,"name":"SOCAZOLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Socazolimab","ZKAB-001","ZKAB001","Zkab001"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL480517","canonicalSmiles":"O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)O)=C(/C=C/c3ccc([N+](=O)[O-])cc3[N+](=O)[O-])CS[C@H]12","inchiKey":"LHNIIDJCEODSHA-OQRUQETBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROCEFIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nitrocefin"],"crossReferences":{"drugbank":["DB11592"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL482858","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(=O)O)[C@H]2SC1","inchiKey":"HOKIDJSKDBPKTQ-GLXFQSAKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOSPORIN C","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cephalosporin c","NSC-757790"],"crossReferences":{"PubChem":["90341458"],"Wikipedia":["Cephalosporin_C"],"drugbank":["DB03313"],"chEBI":["15776"]},"childChemblIds":["CHEMBL1326149","CHEMBL3138667"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489799","canonicalSmiles":"O=C(NC(=O)c1ccccc1)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"JSBCZGSPFATCOV-BZNQNGANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489799","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506871","canonicalSmiles":"C[C@]1(c2nc3cccc(C(N)=O)c3[nH]2)CCCN1","inchiKey":"JNAHVYVRKWKWKQ-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELIPARIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-888","PARP-1 INHIBITOR ABT-888","Veliparib"],"crossReferences":{"drugbank":["DB07232"],"chEBI":["62880"]},"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_1000412","EFO_0001075","MONDO_0015686","EFO_1001465","EFO_1000657","MONDO_0007254","EFO_0000708","EFO_1001469","EFO_0005952","EFO_0000305","EFO_0002917","EFO_1000357","EFO_1001951","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0006462","MONDO_0015760","EFO_0003968","MONDO_0002898","EFO_0000182","EFO_0002499","EFO_1000042","EFO_0002617","EFO_1000158","EFO_0000616","EFO_0002618","Orphanet_145","EFO_0005088","EFO_0000466","MONDO_0008170","EFO_1000435","EFO_0003060","MONDO_0008315","EFO_0001663","EFO_0000311","EFO_0006772","EFO_0006861","EFO_0005537","EFO_0000702","EFO_0000574","EFO_1000252","MONDO_0024880","EFO_0000519","EFO_1000494"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 34 investigational indications."}
{"id":"CHEMBL508102","canonicalSmiles":"CCOC(=O)n1ccn(C)c1=S","inchiKey":"CFOYWRHIYXMDOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBIMAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neo-mercazole 20","Neo-mercazole 5"],"synonyms":["Athyromazole","Carbimazol henning","Carbimazole","NSC-758966"],"crossReferences":{"PubChem":["11112670","144204147","144212637","170465583","26749040"],"Wikipedia":["Carbimazole"],"drugbank":["DB00389"],"chEBI":["617099"]},"linkedTargets":{"rows":["ENSG00000115705"],"count":1},"linkedDiseases":{"rows":["EFO_0009190","HP_0000820"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for abnormality of the thyroid gland and has 1 investigational indication."}
{"id":"CHEMBL50882","canonicalSmiles":"Nc1n[n+]([O-])c2ccccc2[n+]1[O-]","inchiKey":"ORYDPOVDJJZGHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRAPAZAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-130181","SR-259075","SR259075","Tirapazamine","WIN 59075","WIN-59075"],"crossReferences":{"Wikipedia":["Tirapazamine"],"drugbank":["DB04858"],"chEBI":["78887"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL522579","canonicalSmiles":"Cc1nnc(-c2ccc(-c3cc(C(=O)NC4CC4)ccc3C)c(C)c2)o1","inchiKey":"UBVTVSINEVHYSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07811"],"chEBI":["90544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550453","canonicalSmiles":"O=C(CN1C[C@H](F)[C@@H](NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F","inchiKey":"SXIYSYYSKHUTQQ-RDJZCZTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL550453","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08143"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559288","canonicalSmiles":"N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1","inchiKey":"IHEHEFLXQFOQJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRITRAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dipidolor","IDS-NP-013","Pirinitramide","Piritramide","R 3365","R-3365"],"crossReferences":{"Wikipedia":["Piritramide"],"drugbank":["DB12492"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL570775","canonicalSmiles":"c1ccc(CNc2ccc(OC[C@H]3CCCN3)cc2)cc1","inchiKey":"HITMFLNAOQIZSN-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL570775","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07260"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL597","canonicalSmiles":"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1","inchiKey":"MRBDMNSDAVCSSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTOLAMINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phentolamin","Phentolamine"],"crossReferences":{"DailyMed":["phentolamine%20mesylate"],"PubChem":["104171285","11112200","124882050","124882053","144203915","170464866","26751465","26751466","26751467","50085867","50100389","50100390","50103967","860967","90341742"],"Wikipedia":["Phentolamine"],"drugbank":["DB00692"],"chEBI":["8081"]},"childChemblIds":["CHEMBL1204146","CHEMBL1200873"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MONDO_0001330","EFO_0000319","HP_0001943","HP_0011499","EFO_0001073","MONDO_0008315","EFO_0000239"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for adrenal gland pheochromocytoma and cardiovascular disease and has 6 investigational indications."}
{"id":"CHEMBL69330","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O","inchiKey":"VWFJDQUYCIWHTN-YFVJMOTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FARNESYL DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Farnesyl Diphosphate"],"crossReferences":{"drugbank":["DB07780"],"chEBI":["17407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL7010","canonicalSmiles":"CCNC1C2CCC(C2)C1c1ccccc1","inchiKey":"IKFBPFGUINLYQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENCAMFAMIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fencamfamin","N06BA06"],"crossReferences":{"Wikipedia":["Fencamfamine"],"drugbank":["DB01463"]},"childChemblIds":["CHEMBL2106270"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL9113","canonicalSmiles":"Cc1ccccc1","inchiKey":"YXFVVABEGXRONW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLUENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antisal 1a","Methacide","NSC-406333","Toluene"],"crossReferences":{"PubChem":["17388690","17389706"],"Wikipedia":["Toluene"],"drugbank":["DB11558"],"chEBI":["17578"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL934","canonicalSmiles":"CC(C)(C(=O)c1cccnc1)c1cccnc1","inchiKey":"FJLBFSROUSIWMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METYRAPONE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metopiron","Metopirone"],"synonyms":["Metyrapone","NSC-25265"],"crossReferences":{"DailyMed":["metyrapone"],"PubChem":["11112126","124881925","170465268","56323421"],"Wikipedia":["Metyrapone"],"drugbank":["DB01011"],"chEBI":["44241"]},"childChemblIds":["CHEMBL3989720"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and has 5 investigational indications."}
{"id":"CHEMBL941","canonicalSmiles":"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1","inchiKey":"KTUFNOKKBVMGRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMATINIB","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Glamox","Gleevec","Imatinib","NSC-743414","NSC-759854","STI-571"],"crossReferences":{"DailyMed":["imatinib%20mesylate"],"PubChem":["103905596","124892207","124892208","124892209","26755316","29215405","50100104"],"Wikipedia":["Imatinib"],"drugbank":["DB00619"],"chEBI":["45783"]},"childChemblIds":["CHEMBL2386595","CHEMBL1642"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716","ENSG00000113721","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0004683","EFO_0001361","EFO_0000365","EFO_0007444","EFO_0000756","MONDO_0000956","EFO_1000657","EFO_1001919","EFO_0005952","EFO_0000497","EFO_0000333","EFO_1001951","EFO_0000565","Orphanet_178","EFO_0000339","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_1001814","EFO_0000641","EFO_0000760","EFO_0000094","EFO_0004288","MONDO_0002715","EFO_0002618","MONDO_0013730","MONDO_0005149","EFO_0000220","EFO_0001642","MONDO_0002108","MONDO_0008170","EFO_0009907","EFO_0000349","EFO_0005842","Orphanet_3389","Orphanet_636","EFO_1001946","MONDO_0044881","EFO_0002429","MONDO_0008315","Orphanet_398934","EFO_1000576","EFO_0001422","EFO_0003032","MONDO_0000544","MONDO_0100096","MONDO_0044917","EFO_0002428","EFO_0000574","MONDO_0004979","EFO_1000613","EFO_0001376","EFO_0004610","Orphanet_232","MONDO_0015686","EFO_0000768","EFO_1001465","MONDO_0007254","EFO_0002087","EFO_0000209","MONDO_0002087","MONDO_0003541","Orphanet_538","HP_0001880","MONDO_0021063","EFO_0002430","MONDO_0001056","MONDO_0002158","Orphanet_31112","EFO_0000712","EFO_0004289","EFO_0000673","EFO_1001361","EFO_1001993","MONDO_0020743","EFO_0000717","MONDO_0002618","EFO_0002617","EFO_1000158","EFO_0002914","EFO_0000616","EFO_0003897","EFO_0000685","EFO_0006859","EFO_0000503","Orphanet_44890","MONDO_0016586","MONDO_0000870","EFO_0000222","EFO_0004198","EFO_0000313","EFO_0003060","MONDO_0003865","EFO_0000311","EFO_1001471","EFO_0000658","MONDO_0005301","EFO_0006861","MONDO_0005147","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","EFO_1000895","EFO_1001467","MONDO_0024880","EFO_0000691","MONDO_0004643","EFO_0000519","EFO_0003956","Orphanet_31837"],"count":112},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 103 investigational indications."}
